Felix J. Herth
Elite in Emphysema

Felix J. Herth

Thoraxklinik
Heidelberg, BW, DE 
Elite in Emphysema
Thoraxklinik
Heidelberg, BW, DE 
OverviewLocationsClinical Research

Overview

Felix Herth practices in Heidelberg, Germany. Mr. Herth is rated as an Elite expert by MediFind in the treatment of Emphysema. His top areas of expertise are Emphysema, Chronic Obstructive Pulmonary Disease (COPD), Lung Cancer, Endoscopy, and Advanced Bronchoscopy.

His clinical research consists of co-authoring 479 peer reviewed articles and participating in 11 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 76 articles and participated in 4 clinical trials in the study of Emphysema.

Gender
Male

Locations

Thoraxklinik
Heidelberg, BW, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

11 Clinical Trials

A Randomized, Double-Blind, Placebo Controlled Study to Assess the Efficacy and Safety of Two Dose Regimens (60 mg/kg and 120 mg/kg) of Weekly Intravenous Alpha1 Proteinase Inhibitor (Human) in Subjects With Pulmonary Emphysema Due to Alpha1 Antitrypsin Deficiency
A Randomized, Double-Blind, Placebo Controlled Study to Assess the Efficacy and Safety of Two Dose Regimens (60 mg/kg and 120 mg/kg) of Weekly Intravenous Alpha1 Proteinase Inhibitor (Human) in Subjects With Pulmonary Emphysema Due to Alpha1 Antitrypsin Deficiency
Enrollment Status: Active_not_recruiting
Publish Date: January 15, 2025
Intervention Type: Biological, Other
Study Drug: Prolastin C
Study Phase: Phase 3
A Multicenter, Randomized, Sham-controlled Study to Evaluate Safety and Efficacy After Treatment with the Nuvaira™ Lung Denervation System in Patients with Chronic Obstructive Pulmonary Disease (COPD)
A Multicenter, Randomized, Sham-controlled Study to Evaluate Safety and Efficacy After Treatment with the Nuvaira™ Lung Denervation System in Patients with Chronic Obstructive Pulmonary Disease (COPD)
Enrollment Status: Active_not_recruiting
Publish Date: November 14, 2024
Intervention Type: Other, Device
Study Phase: Not Applicable
Fissure Closure With the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema; A Multicenter, Prospective Trial
Fissure Closure With the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema; A Multicenter, Prospective Trial
Enrollment Status: Completed
Publish Date: November 04, 2024
Intervention Type: Device
Study Phase: Not Applicable
Evaluation of the Free Flow Medical Lung Tensioning Device System for the Treatment of Severe Emphysema - EFFORT
Evaluation of the Free Flow Medical Lung Tensioning Device System for the Treatment of Severe Emphysema - EFFORT
Enrollment Status: Completed
Publish Date: November 21, 2023
Intervention Type: Device
Study Phase: Not Applicable
A Randomized Controlled Study of PneumRx Endobronchial Coil System Versus Standard-of-Care Medical Management in the Treatment of Subjects With Severe Emphysema
A Randomized Controlled Study of PneumRx Endobronchial Coil System Versus Standard-of-Care Medical Management in the Treatment of Subjects With Severe Emphysema
Enrollment Status: Completed
Publish Date: August 28, 2023
Intervention Type: Device
Study Phase: Not Applicable
Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Inhalation to Prevent ARDS in COVID-19 Pneumonia (GI-COVID)
Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Inhalation to Prevent ARDS in COVID-19 Pneumonia (GI-COVID)
Enrollment Status: Completed
Publish Date: May 10, 2023
Intervention Type: Drug, Other
Study Drug: Molgramostim
Study Phase: Phase 2
A Prospective Safety and Feasibility Study of the RejuvenAir™ System Metered Cryospray Therapy for Chronic Bronchitis Patients
A Prospective Safety and Feasibility Study of the RejuvenAir™ System Metered Cryospray Therapy for Chronic Bronchitis Patients
Enrollment Status: Completed
Publish Date: February 23, 2023
Intervention Type: Device
Study Phase: Not Applicable
Percutaneous Temporary Placement of a Phrenic Nerve Stimulator for Diaphragm Pacing
Percutaneous Temporary Placement of a Phrenic Nerve Stimulator for Diaphragm Pacing
Enrollment Status: Completed
Publish Date: November 16, 2022
Intervention Type: Device
Study Phase: Not Applicable
A Sequential Two Phase Multicenter, Randomized Study to Optimize Dose Selection and Evaluate Safety After Treatment With the Holaira™ Lung Denervation System in Patients With Moderate to Severe COPD.
A Sequential Two Phase Multicenter, Randomized Study to Optimize Dose Selection and Evaluate Safety After Treatment With the Holaira™ Lung Denervation System in Patients With Moderate to Severe COPD.
Enrollment Status: Completed
Publish Date: April 13, 2022
Intervention Type: Device
Study Phase: Not Applicable
A pRospective, Multicenter, Single-arm Study EvaLuating the Safety and feasIbility of Targeted Lung Denervation (TLD) for the trEatment oF Severe Asthma
A pRospective, Multicenter, Single-arm Study EvaLuating the Safety and feasIbility of Targeted Lung Denervation (TLD) for the trEatment oF Severe Asthma
Enrollment Status: Terminated
Publish Date: April 12, 2022
Intervention Type: Device
Study Phase: Not Applicable
Evaluation of the Archimedes™ System for Transparenchymal Nodule Access 2
Evaluation of the Archimedes™ System for Transparenchymal Nodule Access 2
Enrollment Status: Completed
Publish Date: November 01, 2019
Intervention Type: Device
Study Phase: Not Applicable
View 10 Less Clinical Trials

479 Total Publications

Study protocol for a multicentre, randomised controlled trial in China to evaluate the efficacy and safety of precise subsegmental bronchoscopic thermal vapour ablation treatment in severe emphysema.
Study protocol for a multicentre, randomised controlled trial in China to evaluate the efficacy and safety of precise subsegmental bronchoscopic thermal vapour ablation treatment in severe emphysema.
Journal: BMJ open
Published: October 09, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Herth's expertise for a condition
ConditionClose
View All 15 Advanced Conditions
View All 45 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile